Gynaekologisch-Onkologische Schwerpunktpraxis Prof. Dr. med. Lueck, Dr. Schrader und Dr. Noeding
Hannover, Germany
Obstetrician-gynecologist in Hanover, Lower Saxony
Pelikanpl. 23, 30177 Hannover
About Gynaekologisch-Onkologische Schwerpunktpraxis Prof. Dr. med. Lueck, Dr. Schrader und Dr. Noeding
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
11
Fondazione Michelangelo
3
AGO Research GmbH
1
AGO Study Group
1
Arcagy Research
1
Elevation Oncology
1
Eli Lilly and Company
1
Gilead Sciences
1
Spanish Breast Cancer Research Group
1
University Hospital Tuebingen
1
Clinical Trials at Gynaekologisch-Onkologische Schwerpunktpraxis Prof. Dr. med. Lueck, Dr. Schrader und Dr. Noeding
During the past decade, Gynaekologisch-Onkologische Schwerpunktpraxis Prof. Dr. med. Lueck, Dr. Schrader und Dr. Noeding conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 11 clinical trials were completed, i.e. on
average, 122.2% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 3 clinical trials were completed. i.e. 150%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Bevacizumab + Endocrine Treatment vs Endocrine Treatment as First Line in Postmenopausal Women
2007-11-06
2014-07-24
Completed
380
Multicenter Trial With PegLiposomal Doxorubicin and Carboplatin Combination Chemotherapy in Gynecological Sarcomas and Mixed Epithelial-Mesenchymal Tumors
2008-06-01
2012-01-01
Completed
41
A Study to Compare Subcutaneous (SC) Versus Intravenous (IV) Administration of Herceptin (Trastuzumab) in Women With Human Epidermal Growth Factor Receptor (HER) 2-Positive Early Breast Cancer
2009-10-16
2017-01-24
Completed
596
AURELIA: A Study of Avastin (Bevacizumab) Added to Chemotherapy in Patients With Platinum-resistant Ovarian Cancer
2009-10-29
2014-07-09
Completed
361
A Study of Trastuzumab Emtansine (T-DM1) Plus Pertuzumab/Pertuzumab Placebo Versus Trastuzumab [Herceptin] Plus a Taxane in Participants With Metastatic Breast Cancer (MARIANNE)
2010-07-31
2016-09-16
Completed
1,095
A Study of Pertuzumab in Addition to Chemotherapy and Trastuzumab as Adjuvant Therapy in Participants With Human Epidermal Growth Receptor 2 (HER2)-Positive Primary Breast Cancer
2011-11-08
2028-11-30
Active, not recruiting
4,804
A Safety and Tolerability Study of Assisted and Self-Administered Subcutaneous (SC) Herceptin (Trastuzumab) as Adjuvant Therapy in Early Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer
2012-05-17
2020-02-19
Completed
2,577
A Study of Pertuzumab in Combination With Trastuzumab (Herceptin) and a Taxane in First-Line Treatment in Participants With Human Epidermal Growth Factor 2 (HER2)-Positive Advanced Breast Cancer
2012-06-01
2019-09-20
Completed
1,436
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Gynaekologisch-Onkologische Schwerpunktpraxis Prof. Dr. med. Lueck, Dr. Schrader und Dr. Noeding" #1 sponsor was "Hoffmann-La Roche" with 11 trials, followed by "Fondazione Michelangelo" with 3 trials
sponsored, "AGO Research GmbH" with 1 trials sponsored, "AGO Study Group" with 1 trials sponsored and "Arcagy Research"
with 1 trials sponsored. Other sponsors include 0 different institutions and
companies that sponsored additional 10 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Gynaekologisch-Onkologische Schwerpunktpraxis Prof. Dr. med. Lueck, Dr. Schrader und Dr. Noeding"
#1 collaborator was "Arbeitsgemeinschaft Gynaekologische Onkologie Austria" with 2 trials as a collaborator, "Breast International Group" with 2 trials as a collaborator, "Genentech, Inc." with 2 trials as a collaborator, "German Breast Group" with 2 trials as a collaborator and "Hoffmann-La Roche" with 2 trials as a collaborator. Other collaborators include 10 different institutions and companies that were
collaborators in the rest 20 trials.
Clinical Trials Conditions at Gynaekologisch-Onkologische Schwerpunktpraxis Prof. Dr. med. Lueck, Dr. Schrader und Dr. Noeding
According to Clinical.Site data, the most researched conditions in "Gynaekologisch-Onkologische Schwerpunktpraxis Prof. Dr. med. Lueck, Dr. Schrader und Dr. Noeding" are
"Breast Cancer" (7 trials), "Breast Neoplasms" (3 trials), "Metastatic Breast Cancer" (3 trials), "Ovarian Cancer" (3 trials) and "Carcinosarcoma" (1 trials). Many other conditions were trialed in "Gynaekologisch-Onkologische Schwerpunktpraxis Prof. Dr. med. Lueck, Dr. Schrader und Dr. Noeding" in a lesser frequency.
Clinical Trials Intervention Types at Gynaekologisch-Onkologische Schwerpunktpraxis Prof. Dr. med. Lueck, Dr. Schrader und Dr. Noeding
Most popular intervention types in "Gynaekologisch-Onkologische Schwerpunktpraxis Prof. Dr. med. Lueck, Dr. Schrader und Dr. Noeding" are "Drug" (21 trials), "Procedure" (2 trials) and "Biological" (1 trials). Other intervention types were less common.
The name of intervention was led by "Paclitaxel" (6 trials), "Carboplatin" (5 trials), "Cyclophosphamide" (5 trials), "Pertuzumab" (5 trials) and "Docetaxel" (4 trials). Other intervention names were less common.
Clinical Trials Genders at Gynaekologisch-Onkologische Schwerpunktpraxis Prof. Dr. med. Lueck, Dr. Schrader und Dr. Noeding
The vast majority of trials in "Gynaekologisch-Onkologische Schwerpunktpraxis Prof. Dr. med. Lueck, Dr. Schrader und Dr. Noeding" are
12 trials for "Female" genders and 10 trials for "All" genders.
Clinical Trials Status at Gynaekologisch-Onkologische Schwerpunktpraxis Prof. Dr. med. Lueck, Dr. Schrader und Dr. Noeding
Currently, there are NaN active trials in "Gynaekologisch-Onkologische Schwerpunktpraxis Prof. Dr. med. Lueck, Dr. Schrader und Dr. Noeding".
undefined are not yet recruiting,
2 are recruiting,
7 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 11 completed trials in Gynaekologisch-Onkologische Schwerpunktpraxis Prof. Dr. med. Lueck, Dr. Schrader und Dr. Noeding,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Gynaekologisch-Onkologische Schwerpunktpraxis Prof. Dr. med. Lueck, Dr. Schrader und Dr. Noeding, 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 19 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".